How do you pitch Advanced Technology Ventures?

The most effective path to Advanced Technology Ventures is a warm introduction from a founder in their portfolio or a trusted co-investor. Use AngelSearch Signal to map your intro paths.

What is Advanced Technology Ventures's typical check size?

Advanced Technology Ventures typically writes checks between $1B and $25B.

What industries does Advanced Technology Ventures focus on?

Advanced Technology Ventures invests in Fintech, Venture Capital.

Advanced Technology Ventures

Venture CapitalActive

Advanced Technology Ventures focuses on investing in the ICT, infrastructure, consumer technology, bio-pharmaceuticals and medical industry.

Menlo Park, United StatesFounded 2005atvcapital.com

238

Investments

Exits

$1.5B

AUM

3.8%

Exit Rate

Get contact info, warm intros & fit scores

Get started free

Investment Thesis & Strategy

Advanced Technology Ventures invests in various stages of companies within the ICT, infrastructure, consumer technology, bio-pharmaceuticals, and medical industries. They seek companies with high growth potential and innovative technologies.

Investment Activity

Deals per year over the last 6 years

2002

2003

2004

2005

2006

2007

Portfolio Companies

Selected investments from their portfolio of 238 companies

Xilinx

Enterprise · Series A, 0

Active

Tivo

Media/Content · Series A, 0

Active

Paradigm Genetics

Biotech · Series A, 0

Active

Aspect Medical Systems

Healthcare · Series A, 0

Active

Vistaprint

E-commerce · Series A, 0

Active

Calera

Cleantech · Series A, 2007

Active

Sirtris Pharmaceuticals

Biotech · Series A, 2004

Active

Silver Spring Networks

IoT · Series A, 2004

Active

NextDocs

SaaS · Series A, 2003

Active

Acceleron Pharma

Biotech · Series A, 2003

Active

A123 Systems

Cleantech · Series A, 2002

Active

Alnylam Pharmaceuticals

Biotech · Series A, 2002

Active

Notable Exits

CompanyTypeYearValue / Acquirer

Zosano PharmaIPO2015—

Vascular BiogenicsIPO2015—

Radius HealthIPO2014—

Acceleron PharmaIPO2013—

Portola PharmaceuticalsIPO2013—

Aegerion PharmaceuticalsIPO2010—

Sirtris PharmaceuticalsAcquisition2008$720M

Genomic HealthIPO2005—

Alnylam PharmaceuticalsIPO2004—

Frequently Asked Questions

Advanced Technology Ventures focuses on Series A, Series B, Series C+ stage investments.

Related Investors

Threshold

Menlo Park, United States · 841 deals

Lightspeed Venture Partners

Menlo Park, United States · 839 deals

Andreessen Horowitz

Menlo Park, United States · 826 deals

Khosla Ventures

Menlo Park, United States · 769 deals

Greylock

Menlo Park, United States · 720 deals

GGV Capital

Menlo Park, United States · 625 deals